Brookstone Capital Management’s Celgene Corp CELG Stock Holding History

Brookstone Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,105	Closed	-$308K	–	490
2019 Q3	$308K	Buy	+3,105	New	+$295K	0.02%	336
2015 Q4	–	Sell	-651	Closed	-$70K	–	1164
2015 Q3	$70K	Hold	651	–	–	0.01%	337
2015 Q2	$75K	Buy	+651	New	+$74.4K	0.01%	391

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Brookstone Capital Management's CELG Position: Q4 2019 in Review

Brookstone Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,105 shares — an estimated $308K sold.

Brookstone Capital Management first reported a position in CELG in Q2 2015 and held it in 3 quarters. The position peaked at $308K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Brookstone Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Brookstone Capital Management sold 3,105 Celgene Corp shares in Q4 2019, an estimated $308K.
Brookstone Capital Management first reported a position in Celgene Corp in Q2 2015 and held it in 3 quarters.
Brookstone Capital Management's Celgene Corp position peaked at $308K in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Brookstone Capital Management's 13F filing for Q4 2019, filed 29 Jan 2020.